Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
QED Clinical Services was a specialist Contract Research Organization (CRO) that provided clinical trial management, monitoring, and resourcing services to the global life sciences industry. Established in 2002 and headquartered in the United Kingdom with significant operations in India, the company focused on delivering flexible and cost-effective clinical development solutions. QED offered expertise across various therapeutic areas, including oncology, cardiology, and respiratory medicine, supporting Phase I through Phase IV clinical trials. In July 2014, the company was acquired by Quanticate, a leading data-focused CRO, to bolster Quanticate's clinical monitoring and site management capabilities. Following the acquisition, QED's operations were integrated into Quanticate's global service delivery model.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on QED Clinical Services.